Lianmin Zhang

机构：Tianjin Medical University Cancer Institute and Hospital, Online Technologies (United States) · ORCID：0000-0002-7419-9628

发表论文 59 篇 · 总被引 1336 次 · h-index 21

代表论文

Leveraging mitochondrial-programmed cell death dynamics to enhance prognostic accuracy and immunotherapy efficacy in lung adenocarcinoma (2024 · Journal for ImmunoTherapy of Cancer · 被引 80)
Novel post-translational modification learning signature reveals B4GALT2 as an immune exclusion regulator in lung adenocarcinoma (2025 · Journal for ImmunoTherapy of Cancer · 被引 79)
Mitochondrial Pathway Signature (MitoPS) predicts immunotherapy response and reveals NDUFB10 as a key immune regulator in lung adenocarcinoma (2025 · Journal for ImmunoTherapy of Cancer · 被引 59)
Exploring cellular diversity in lung adenocarcinoma epithelium: Advancing prognostic methods and immunotherapeutic strategies (2024 · Cell Proliferation · 被引 52)
Deciphering lung adenocarcinoma evolution: Integrative s ingle‐cell genomics identifies the prognostic lung progression associated signature (2024 · Journal of Cellular and Molecular Medicine · 被引 43)
Integrating machine learning and single‐cell analysis to uncover lung adenocarcinoma progression and prognostic biomarkers (2024 · Journal of Cellular and Molecular Medicine · 被引 31)